HueDx

HueDx

Accelerating quantitative testing in Medical, R&D, Agro, & Industrial sectors

Print
Claim My Business
Security Type
Crowd SAFE
Min Investment
$100
Location
PHILADELPHIA, PA
Offering Date
June 23, 2023
Expected Close Date
August 25, 2023
Target Raise
$50.00K-$1.24M
No. Investors
66
Security Price
$1
Website
huedx.com
Number of Employees
10
Cash
$37,320
Revenue
$0
Short Term Debt
$337,610
Cost of Goods
$0
Long Term Debt
$180,005
Net Income
$-1,617,497

Company Description

A Rapid Assay is a technology that measures the presence ("yes"/"no") of substance in a sample, such as contaminant in water or a virus such as COVID. Rapid Quantitative Assays (RQAs); however, are a subtype of assay that allows for near-immediate, lab-grade test results with added precision and decision-making power, because they measure how much of a substance is present in a sample.

Perks

4 investors
Invest
$1,000
Receive
A HueCard
Limited (21 left of 25)

1 investor
Invest
$2,500
Receive
A virtual meeting with a member of our leadership team
A HueCard
Limited (4 left of 5)

Invest
$5,000
Receive
A virtual meeting with a member of our leadership team
A HueCard
A HueCard Demo Kit
Limited (10 left of 10)

1 investor
Invest
$10,000
Receive
A virtual meeting with a member of our leadership team
A HueCard
A HueCard Demo Kit
A full in-depth demo of our HueCloud Assay Development Tools.
Limited (1 left of 2)

Key Deal Facts

Technology platform for developing and launching rapid diagnostic tests
Applications in Medicine, Agriculture, Manufacturing, R&D, Industrial +
Flagship product launched Feb '23 | Multiple $1M+ opportunities in funnel
Reduces industry-standard assay development time from years to months
Results in minutes — in lab, at home, or anywhere — with only smartphone

Management Team / Advisory Board Bios

Mark Wingertzahn
CEO
Mark is the CEO of HueDx. As a seasoned pharma and biotech exec, Mark joined HueDx first as an investor, and then CEO. Mark brings his innovative leadership to HueDx as it closes its first contracts and enters a revenue-generating era.

Brianna Wronko-Stevens
CSO and Founder
Brianna is the Founder & CSO at HueDx. Brianna is a biotechnology innovator who has focused her career on overhauling the diagnostic process for both patient and consumer.

Sam Parks
CTO
Sam is a founder, engineer, scientist, and CTO. His experience began in nanotechnology and quantum engineering and evolved into founding multi-hundred-million dollar, globally-successful companies.
Amount Raised : $53,091
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments